中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

铁死亡的发生机制及其在非酒精性脂肪性肝病/非酒精性脂肪性肝炎发生发展中的作用

刘鸣昊 刘素彤 张丽慧 顾亚娇 尚东方 肖准 赵文霞

引用本文:
Citation:

铁死亡的发生机制及其在非酒精性脂肪性肝病/非酒精性脂肪性肝炎发生发展中的作用

DOI: 10.3969/j.issn.1001-5256.2022.05.037
基金项目: 

国家自然科学基金 (81904154);

河南省科技攻关计划 (202102310168);

河南省重点研发与推广专项课题 (192102310425);

河南省中医药科学研究专项课题 (2019JDZX2051);

河南省科技攻关计划项目 (202102310495);

河南省特色骨干学科中医学学科建设项目 (STG-ZYXKY-2020024)

利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:赵文霞负责拟定题目和文章框架:刘素彤负责撰写论文; 张丽慧、顾亚娇、尚东方、肖准负责修改论文; 刘鸣昊负责拟定写作思路,指导撰写文章并最后定稿。
详细信息
    通信作者:

    赵文霞,zhao-wenxia@163.com

Mechanism of ferroptosis in the formation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Research funding: 

National Natural Science Foundation of China (81904154);

The Science and Technology Research Program of Henan Province (202102310168);

Key Research and Promotion Project of Henan Province (192102310425);

Traditional Chinese Medicine Science Research Project of Henan Province (2019JDZX2051);

Key Science and Technology Project of Henan Province (202102310495);

TCM Discipline Construction Project of Characteristic Backbone Disciplines of Henan Province (STG-ZYXKY-2020024)

More Information
  • 摘要: 铁死亡是脂质过氧化驱动、铁依赖的细胞死亡。发生机制与铁稳态失衡、脂质过氧化及SLC7A11-GSH-GPX4抗氧化系统有关。在非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)的发生发展中发挥关键作用。抑制铁死亡,几乎可以完全抑制NASH发生。通过对铁死亡发生机制及其在NAFLD/NASH疾病中的作用和进展进行综述,并提出铁死亡研究的策略和技术手段,以期为NAFLD/NASH机制研究提供参考。

     

  • 图  1  铁死亡的发生机制

    注:a, System Xc—GSH-GPX4轴与铁死亡发生机制; b,脂质过氧化与铁死亡发生机制; c,铁稳态失衡与铁死亡发生机制。NCOA4,自噬特异性识别蛋白核受体辅激活因子4;TCA循环,三羧酸循环; Fe2+,二价亚铁离子; Fe3+,三价铁离子; GSH,谷胱甘肽; GPX4,谷胱甘肽过氧化酶4。

    Figure  1.  The mechanism of ferroptosis

  • [1] YOUNOSSI Z, ANSTEE QM, MARIETTI M, et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(1): 11-20. DOI: 10.1038/nrgastro.2017.109.
    [2] MANNE V, HANDA P, KOWDLEY KV. Pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J]. Clin Liver Dis, 2018, 22(1): 23-37. DOI: 10.1016/j.cld.2017.08.007.
    [3] TSURUSAKI S, TSUCHIYA Y, KOUMURA T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis[J]. Cell Death Dis, 2019, 10(6): 449. DOI: 10.1038/s41419-019-1678-y.
    [4] STOCKWELL BR, FRIEDMANN ANGELI JP, BAYIR H, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell, 2017, 171(2): 273-285. DOI: 10.1016/j.cell.2017.09.021.
    [5] JHELUM P, SANTOS-NOGUEIRA E, TEO W, et al. Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination[J]. J Neurosci, 2020, 40(48): 9327-9341. DOI: 10.1523/JNEUROSCI.1749-20.2020.
    [6] REICHERT CO, DE FREITAS FA, SAMPAIO-SILVA J, et al. Ferroptosis mechanisms involved in neurodegenerative diseases[J]. Int J Mol Sci, 2020, 21(22). DOI: 10.3390/ijms21228765.
    [7] HOU W, XIE Y, SONG X, et al. Autophagy promotes ferroptosis by degradation of ferritin[J]. Autophagy, 2016, 12(8): 1425-1428. DOI: 10.1080/15548627.2016.1187366.
    [8] QIAO YX, WANG B, XUE WJ, et al. Advancement of research on ferroptosis in acute kidney injury[J]. Ogran Transplant, 2020, 11(6): 671-676. DOI: 10.3969/j.issn.1674-7445.2020.06.004.

    乔予希, 王博, 薛武军, 等. 急性肾损伤过程中铁死亡的研究进展[J]. 器官移植, 2020, 11(6): 671-676. DOI: 10.3969/j.issn.1674-7445.2020.06.004.
    [9] QUILES DEL REY M, MANCIAS JD. NCOA4-mediated ferritinophagy: A potential link to neurodegeneration[J]. Front Neurosci, 2019, 13: 238. DOI: 10.3389/fnins.2019.00238.
    [10] KANG R, ZHU S, ZEH HJ, et al. BECN1 is a new driver of ferroptosis[J]. Autophagy, 2018, 14(12): 2173-2175. DOI: 10.1080/15548627.2018.1513758.
    [11] SONG X, ZHU S, CHEN P, et al. AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X(c)(-) activity[J]. Curr Biol, 2018, 28(15): 2388-2399. e5. DOI: 10.1016/j.cub.2018.05.094.
    [12] LI J, CAO F, YIN HL, et al. Ferroptosis: Past, present and future[J]. Cell Death Dis, 2020, 11(2): 88. DOI: 10.1038/s41419-020-2298-2.
    [13] CHO SH, CHO YJ, PARK JH. The human symbiont Bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism[J]. J Microbiol, 2022, 60(1): 118-127. DOI: 10.1007/s12275-022-1614-1.
    [14] WEILAND A, WANG Y, WU W, et al. Ferroptosis and its role in diverse brain diseases[J]. Mol Neurobiol, 2019, 56(7): 4880-4893. DOI: 10.1007/s12035-018-1403-3.
    [15] KILLION EA, REEVES AR, EL AZZOUNY MA, et al. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction[J]. Mol Metab, 2018, 9: 43-56. DOI: 10.1016/j.molmet.2018.01.012.
    [16] DOLL S, PRONETH B, TYURINA YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13(1): 91-98. DOI: 10.1038/nchembio.2239.
    [17] DUAN J, WANG Z, DUAN R, et al. Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice[J]. Hepatology, 2022, 75(1): 140-153. DOI: 10.1002/hep.32148.
    [18] MIKULSKA-RUMINSKA K, ANTHONYMUTHU TS, LEVKINA A, et al. NO(●) represses the oxygenation of arachidonoyl PE by 15LOX/PEBP1: Mechanism and role in ferroptosis[J]. Int J Mol Sci, 2021, 22(10): 5253. DOI: 10.3390/ijms22105253.
    [19] WU X, LIU C, LI Z, et al. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer[J]. Mol Cell Biochem, 2020, 473(1-2): 217-228. DOI: 10.1007/s11010-020-03821-8.
    [20] ZOU Y, LI H, GRAHAM ET, et al. Author correction: Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis[J]. Nat Chem Biol, 2021, 17(4): 501. DOI: 10.1038/s41589-021-00767-w.
    [21] DIXON SJ, LEMBERG KM, LAMPRECHT MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072. DOI: 10.1016/j.cell.2012.03.042.
    [22] STOCKWELL BR, FRIEDMANN ANGELI JP, BAYIR H, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell, 2017, 171(2): 273-285. DOI: 10.1016/j.cell.2017.09.021.
    [23] JHELUM P, SANTOS-NOGUEIRA E, TEO W, et al. Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination[J]. J Neurosci, 2020, 40(48): 9327-9341. DOI: 10.1523/JNEUROSCI.1749-20.2020.
    [24] REICHERT CO, de FREITAS FA, SAMPAIO-SILVA J, et al. Ferroptosis mechanisms involved in neurodegenerative diseases[J]. Int J Mol Sci, 2020, 21(22): 8756. DOI: 10.3390/ijms21228765.
    [25] HSIEH CH, LIN YJ, CHEN WL, et al. HIF-1α triggers long-lasting glutamate excitotoxicity via system x(c)(-) in cerebral ischaemia-reperfusion[J]. J Pathol, 2017, 241(3): 337-349. DOI: 10.1002/path.4838.
    [26] KOWDLEY KV, BELT P, WILSON LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease[J]. Hepatology, 2012, 55(1): 77-85. DOI: 10.1002/hep.24706.
    [27] PIERANTONELLI I, SVEGLIATI-BARONI G. Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in the progression from NAFLD to NASH[J]. Transplantation, 2019, 103(1): e1-e13. DOI: 10.1097/TP.0000000000002480.
    [28] FENG Y, LI CJ, ZHANG C. Correlation analysis of iron metabolism in patients with nonalcoholic fatty liver disease[J]. J Clin Int Med, 2011, 28(6): 409-411. DOI: 10.3969/j.issn.1001-9057.2011.06.018

    冯烨, 李成江, 张楚. 非酒精性脂肪肝病与铁代谢异常的相关性分析[J]. 临床内科杂志, 2011, 28(6): 409-411. DOI: 10.3969/j.issn.1001-9057.2011.06.018
    [29] VIOLI F, CANGEMI R. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis[J]. N Engl J Med, 2010, 363(12): 1185-1186; author reply 1186. DOI: 10.1056/NEJMc1006581.
    [30] YU Y, JIANG L, WANG H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis[J]. Blood, 2020, 136(6): 726-739. DOI: 10.1182/blood.2019002907.
    [31] ZHANG FY, ADILA YKP, ZHAO JM, et al. Mechanism of ferroptosis and its role in liver diseases[J]. J Clin Hepatol, 2021, 37(6): 1454-1458. DOI: 10.3969/j.issn.1001-5256.2021.06.049.

    张飞宇, 阿迪拉·亚克普, 赵金明, 等. 铁死亡的发生机制及在肝脏疾病中的作用[J]. 临床肝胆病杂志, 2021, 37(6): 1454-1458. DOI: 10.3969/j.issn.1001-5256.2021.06.049.
    [32] TANG D, CHEN X, KANG R, et al. Ferroptosis: Molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2): 107-125. DOI: 10.1038/s41422-020-00441-1.
    [33] MOU Y, WANG J, WU J, et al. Ferroptosis, a new form of cell death: Opportunities and challenges in cancer[J]. J Hematol Oncol, 2019, 12(1): 34. DOI: 10.1186/s13045-019-0720-y.
    [34] LI N, WANG W, ZHOU H, et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury[J]. Free Radic Biol Med, 2020, 160: 303-318. DOI: 10.1016/j.freeradbiomed.2020.08.009.
    [35] QI J, KIM JW, ZHOU Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice[J]. Am J Pathol, 2020, 190(1): 68-81. DOI: 10.1016/j.ajpath.2019.09.011.
    [36] TSURUSAKI S, TSUCHIYA Y, KOUMURA T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis[J]. Cell Death Dis, 2019, 10(6): 449. DOI: 10.1038/s41419-019-1678-y.
  • 加载中
图(1)
计量
  • 文章访问数:  734
  • HTML全文浏览量:  1088
  • PDF下载量:  166
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-01-20
  • 出版日期:  2022-05-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回